Breast Cancer

Latest News

Patient satisfaction was higher amongst women who underwent chest wall perforator flap technique when compared with other techniques.| Image Credit: AdobeStock_ H_Ko.jpeg
Patient Satisfaction Higher With Certain Breast Reconstruction Techniques

August 12th 2025

Patient satisfaction was higher amongst patients who underwent a chest wall perforator flap reconstruction surgery as part of their breast cancer treatment when compared with other surgical techniques.

Supplemental breast cancer screenings criteria leaves Black women ineligible despite high percentage of false-negative mammograms. | Image Credit: breastcancerscreening-H_Ko.jpeg
Supplemental Breast Cancer Screening Law Renders Many High-Risk Black Women Ineligible

August 5th 2025

Black women are at a higher risk for breast cancer mortality due to social determinants of health and lack of inclusivity in breast cancer genome research. | Image credit: Stafeeva - stock.adobe.com.jpeg
Social Disparities Increase Breast Cancer Mortality for Black Women

July 27th 2025

Early-onset breast cancer found to be associated with certain hormone therapy usage in younger women. | Image Credit: Chinnapong - stock.adobe.com
Hormone Therapy Use May Impact Early-Onset Breast Cancer Risk

July 26th 2025

Menopausal hormone therapy is associated with a higher risk of developing certain breast cancer subtypes. | Image Credit: vectorfusionart - stock.adobe.com
Hormone Therapy Use Differentially Associated With Breast Cancer Subtypes

July 16th 2025

Advances in CDK4/6 Inhibitor Use in High-Risk Early Breast Cancer: 2024 Updates

Experts discuss the impact of CDK4/G inhibitor use, including medication cost, total care costs, toxicity profiles, and strategies to manage and optimize patient outcomes in high-risk early breast cancer.

Watch the latest AJMC Peer Exchange on Advances in CDK4/6 Inhibitor Use in High-Risk Early Breast Cancer: 2024 Updates

More News

Women Value Different Aspects of Care in Breast Reconstruction
November 10th 2023

Women Value Different Aspects of Care in Breast Reconstruction

Julia Bonavitacola
Women of varying backgrounds, educational levels, and marriage status opted for different types of breast reconstruction based on different values.
FDA on textured paper | Image Credit: Araki Illustrations - stock.adobe.com
November 6th 2023

Rhenium Obisbemeda for Breast Cancer, Leptomeningeal Metastases Receives ODD From FDA

Jordyn Sava
Rhenium (186Re) obisbemeda (Plus Therapeutics) shows potential to address the unmet need of new treatment options for patients with breast cancer and leptomeningeal metastases and will continue to be evaluated in the ReSPECT-LM program. The orphan drug designation (ODD) was granted on November 3.
SDOH Social Determinants Of Health Concept - The meeting at the white office table | Image Credit: STOATPHOTO - stock.adobe.com
November 4th 2023

Wide Variation Seen in County-Level Breast Cancer Mortality Linked to SDOH

Maggie L. Shaw
Data from 2176 US counties link obesity and higher breast cancer mortality, while also showing varying degrees of association between mortality and access to healthy lifestyle options per social determinants of health (SDOH).
Afreen Idris Shariff, MD, MBBS, Duke Cancer Institute
November 2nd 2023

Dr Afreen Idris Shariff: Cancer Care Can Transform Through e-Consults

Pearl Steinzor Maggie L. Shaw
Afreen Shariff, MD, MBBS, Duke Cancer Institute, discusses the challenges and benefits of electronic consults (e-consults) for patients with cancer currently undergoing treatment who have a comorbidity history or who develop an endocrine system disorder because of treatment.
Kristine Slam, MD< FACP, Central Ohio Surgical Associates
October 29th 2023

Dr Kristine Slam: Patients With Breast Cancer Must Advocate for Themselves

Maggie L. Shaw
Kristine Slam, MD, FACP, discusses the importance of genetic testing in male patients with breast cancer and why it’s important that all patients with breast cancer advocate for themselves.
Mike Koroscik, MBA, MHA, Allina Health and the Allina Health Cancer Institute
October 26th 2023

Allina Health’s Mike Koroscik on Revolutionizing Early Cancer Detection Through Technology

Pearl Steinzor Maggie L. Shaw
Through the integration of a population health reimbursement model in 2020, Allina Health Cancer Institute was able to implement expanded screening initiatives through the use of artificial intelligence and precision medicine, according to Mike Koroscik, MBA, MHA, vice president of oncology, Allina Health.
Image of women with breast cancer - Vasyl - stock.adobe.com.jpe.jpg
October 25th 2023

Racial, Ethnic Disparities Seen in Breast Cancer Survival, Even Among Clinical Trial Participants

Pearl Steinzor
It is critical to understand the role race and ethnicity play in survival for patients with early-stage breast cancer (eBC), as well as explore potential interventions to close these gaps.
Woman undergoing mammography | Image credit: Peakstock - stock.adobe.com
October 21st 2023

Opt-In vs Opt-Out Patient Outreach Programs Yield Similar Mammography Completion Rates

Skylar Jeremias
No differences in mammography completion were observed between an automated opt-out vs an opt-in patient outreach program for breast cancer screening, according to a randomized controlled trial. However, differences in administration burden between programs could lead clinics to prefer one over the other.
Breast cancer with lymphatics | Image Credit: Axel Kock - stock.adobe.com
October 19th 2023

Low Adherence to Endocrine Therapy Highlights Urgent Need in the Breast Cancer Space

Maggie L. Shaw
Study investigators note their meta-analysis may be the first to demonstrate the importance of interventions to support adherence to adjuvant endocrine therapy for breast cancer.
Kristine Sllam, MD, FACP, Central Ohio Surgical Associates
October 16th 2023

Dr Kristine Slam: In Breast Cancer, Patient Values and Treatment Goals May Differ

Maggie L. Shaw
Kristine Slam, MD, FACP, Central Ohio Surgical Associates, addresses the importance of involving patients in decisions regarding their goals for treatment, emphasizing that this involvement is critical to uncover what they value, as well as their short- and long-term goals for treatment.
Scott Gray, cofounder and CEO, Clincierge | Image Credit: Clincierge
October 11th 2023

Contributor: Advancing Breast Cancer Treatment—The Role of Clinical Trials and the Path Ahead

Scott Gray
Clinical studies have transformed how breast cancer is prevented, identified, and treated. Successful clinical trials improve patient outcomes, so trial administrators must ensure participants receive appropriate support at trial enrollment.
What We’re Reading: Robotic Mastectomies; Racial Discrimination in Maternity Care
October 9th 2023

What We’re Reading: Robotic Mastectomies; Maternity Care Discrimination; Ongoing Kaiser Permanente Strike Issues

AJMC Staff
A minimally invasive procedure could revolutionize breast surgery; Black women experience the worst birthing outcomes; Kaiser Permanente health workers' concerns over labor disputes persist.
FDA on Paper Texture - Araki Illustrations - stock.adobe.com
October 6th 2023

FDA Grants Fast Track Designation to IDE161 for Select Pretreated BRCA1/2-Mutated HR+ Breast Cancer

Kristi Rosa
The FDA has granted fast track designation to IDE161 for use in adult patients with advanced or metastatic hormone receptor–positive, HER2-negative breast cancer harboring BRCA1/2 mutations who have progressed after at least 1 hormonal therapy, a CDK4/6 inhibitor, and a poly (ADP-ribose) polymerase inhibitor.
Kristine Slam, MD, Central Ohio Surgical Associates
October 3rd 2023

Dr Kristine Slam Discusses Preoperative Practices to Increase Treatment Value for Patients With Breast Cancer

Maggie L. Shaw
In this interview from our recent Institute for Value-Based Medicine® event, Kristine Slam, MD, FACP, Central Ohio Surgical Associates, discusses the positive impact that Choosing Wisely and enhanced recovery after surgery, or EROS, protocols have had on patients receiving treatment for breast cancer.
Computer Screen in Hospital Radiology Room: Beautiful Multiethnic Adult Woman Standing Topless Undergoing Mammography Screening Procedure. Screen Showing the Mammogram Scans of Dense Breast Tissues | Image Credit: Gorodenkoff - stock.adobe.com
September 29th 2023

Dato-Dxd Shows Survival Improvements in HR+/HER2– Breast Cancer

Jordyn Sava
The dual primary end points of overall survival and progression-free survival were encouraging when patients with hormone receptor–positive (HR+), HER2-negative (HER2–) breast cancer were treated with datopotamab deruxtecan.
Senior woman having mammography scan at hospital with medical technician. Mammography procedure, breast cancer prevention | Image Credit: Peakstock
September 26th 2023

Older Women Have High Rate of Breast Cancer Overdiagnosis

Maggie L. Shaw
Data from fee-for-service Medicare claims that were linked to the Surveillance, Epidemiology, and End Results program were used for this retrospective cohort analysis among women 70 years and older.
pink mask from COVID19 and breast cancer hold by woman hands | Image Credit Sin Filtro
September 22nd 2023

Breast Cancer Risk Linked to Air Pollution Exposure

Maggie L. Shaw
Data from 6 states—California, Florida, Louisiana, New Jersey, North Carolina, and Pennsylvania—and 2 metropolitan areas—Atlanta, Georgia, and Detroit, Michigan—collected through the National Institutes of Health–AARP Diet and Health Study were used for the investigation.
Kristine Slam, MD, FACP, Central Ohio Surgical Associates
September 19th 2023

Dr Kristine Slam: Value-Based Care in Breast Cancer Requires Collaboration

Maggie L. Shaw
In this interview from our Institute for Value-Based Medicine® event, held in partnership with the Zangmeister Cancer Center of Columbus, Ohio, on September 14, Kristine Slam, MD, FACP, Central Ohio Surgical Associates, discusses the benefits of value-based care in the breast cancer space.
Breast cancer | Image credit: Axel Kock – stock.adobe.com
September 16th 2023

Diet and Exercise Intervention Associated With Better pCR in TNBC or HR+, HER2– BC

Hayley Virgil
Despite seeming to elicit more pathological complete responses (pCRs) in patients with hormone receptor–positive (HR+), HER2-negative triple-negative breast cancer (BC) receiving neoadjuvant chemotherapy, diet and exercise did not affect relative dose intensity.
diverse group of women wearing pink for breast cancer | Image credit: Rawpixel.com - stock.adobe.com
September 15th 2023

Regional Disparities Remain in Breast Reconstruction for Patients With Breast Cancer

Laura Joszt, MA
While regional variations were identified in rates of breast reconstruction, complications, and cost for patients with breast cancer, these differences did not seem to be associated with any implicit bias.
Breast cancer with lymphatics, medically 3D illustration | Image credit: Axel Kock - stock.adobe.com
September 8th 2023

Condensed Proton Therapy Schedule Shows Promise for Patients With Breast Cancer

Hayden E. Klein
New research suggests conventional fractionated and hypofractionated proton postmastectomy radiotherapy (PMRT) yield similar tolerability and complication rates for patients following mastectomy.
Using Genomic Assays to Learn Which Patients With Breast Cancer Could Get Less Treatment
September 5th 2023

Using Genomic Assays to Learn Which Patients With Breast Cancer Could Get Less Treatment

Mary Caffrey
Coverage from the July 25, 2023, session of the Institute for Value-Based Medicine®, presented by The American Journal of Managed Care® in partnership with Emory's Winship Cancer Institute.
Helping Patients Overcome Health Disparities as a Patient Advocate
August 29th 2023

Helping Patients Overcome Health Disparities as a Patient Advocate

An expert reviews the role of the patient advocate in ensuring that health disparities in metastatic breast cancer are overcome.
Patient Advocate's Role in Shared Decision Making
August 29th 2023

Patient Advocate's Role in Shared Decision Making

An expert describes the patient advocate’s role in shared decision-making with a patient for novel therapeutic options.
Guiding Patients Through Complex Treatment Decisions
August 22nd 2023

Guiding Patients Through Complex Treatment Decisions

An expert reviews best practices for assisting and guiding patients in their journey when navigating complex treatment decisions and options.
Helping Patients With Metastatic Breast Cancer Enroll in Clinical Trials
August 22nd 2023

Helping Patients With Metastatic Breast Cancer Enroll in Clinical Trials

Sonya Negley, IOM, CSMA, describes the patient advocate’s role in helping patients with metastatic breast cancer discover and enroll in clinical trials.
Empowering Patients With Metastatic Breast Cancer
August 15th 2023

Empowering Patients With Metastatic Breast Cancer

Sonya Negley, IOM, CSMA, discusses ways to help patients with metastatic breast cancer feel empowered during their journey.
How Patient Advocates Can Help the Newly Diagnosed
August 15th 2023

How Patient Advocates Can Help the Newly Diagnosed

Sonya Negley, IOM, CSMA, reviews how patient advocates can help patients newly diagnosed with metastatic breast cancer.
In Reversal, USPSTF Draft Recommendation Calls for Breast Cancer Screening at Age 40
May 9th 2023

In Reversal, USPSTF Draft Recommendation Calls for Breast Cancer Screening at Age 40

Mary Caffrey
The task force was motivated by a gap between in breast cancer deaths between Black and White women.
Debra Patt, MD, PhD, MBA, executive vice president, Texas Oncology
April 19th 2023

Dr Debra Patt Addresses Concerns Around Hormonal Birth Control and Breast Cancer Risk

Pearl Steinzor
Debra Patt, MD, PhD, MBA, executive vice president at Texas Oncology, explains the small potential risk of breast cancer associated with hormonal birth control.
<123456789
...
13>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo